drugset / Trial / NCT00355628
Clinical Study of KW-2246 in Patients With Cancer Pain
NaSingle-groupOpen-labelTreatment
Summary
This study is a Phase II open-label study to investigate the recommended conversion ratio (oral morphine dose to KW-2246) when switching oral morphine or oxycodone to KW-2246 in cancer patients.
Timeline
- Start
- 2006-07
- Primary completion
- 2007-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | — | — |